These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7878605)

  • 21. [Heparins, antivitamins K. Principles and rules for their use. Dosage of non-fractionated heparins].
    Sié P
    Rev Prat; 1998 Jun; 48(12):1361-5. PubMed ID: 9781198
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with regional anesthesia in patients receiving low molecular weight heparins.
    Wolf H
    Semin Thromb Hemost; 1993; 19 Suppl 1():152-4. PubMed ID: 8395718
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
    Maroto-Iitani M; Higaki Y; Kawashima M
    Contact Dermatitis; 2005 Apr; 52(4):228-30. PubMed ID: 15859998
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intolerance of fondaparinux in a patient allergic to heparins.
    Hirsch K; Ludwig RJ; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2004 Jun; 50(6):383-4. PubMed ID: 15274739
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complications of heparin administration].
    Matýsková M; Buliková A
    Vnitr Lek; 2006 Mar; 52 Suppl 1():92-7. PubMed ID: 16637456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparins in the new millennium: will unfractionated heparin survive? Introduction.
    McClatchey KD; Galvin HM; Galvin RM
    Semin Thromb Hemost; 2000; 26 Suppl 1():3-4. PubMed ID: 11011801
    [No Abstract]   [Full Text] [Related]  

  • 32. The heparins: all a surgeon should know.
    Fujita T
    Surgery; 2008 Jun; 143(6):835. PubMed ID: 18549904
    [No Abstract]   [Full Text] [Related]  

  • 33. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significant high levels of transaminases in a patient with choledocholithiasis].
    Blanco J; Cortés Lopera E; Ribera E; Martínez-Vázquez JM
    An Med Interna; 1994 Aug; 11(8):414-5. PubMed ID: 7772696
    [No Abstract]   [Full Text] [Related]  

  • 35. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 36. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What length of follow-up in patients with HIV and hepatitis C virus coinfection is necessary to consider the level of transaminases to be "persistently normal"?
    Pérez-Guerrero P; Blanco MJ; Martínez-Sierra C; Arizcorreta A; Girón-González JA
    Clin Infect Dis; 2007 Jan; 44(2):310-1. PubMed ID: 17173237
    [No Abstract]   [Full Text] [Related]  

  • 38. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significant increase in transaminases in a patient with acute calculous cholecystitis].
    Perello Roso A; Soriano Melchor E; Mico Giner ML; Aldeguer JL
    An Med Interna; 1997 Feb; 14(2):104. PubMed ID: 9206509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.